450 results on '"Nielsen, Peter Brønnum"'
Search Results
2. Positive predictive value and sensitivity of cancer-associated venous thromboembolism diagnoses in the Danish National Patient Register
3. Adherence and Persistence to Antiplatelet Therapy in Lower Extremity Peripheral Arterial Disease: A Danish Population Based Cohort Study
4. Burden of intracerebral haemorrhage in Europe: forecasting incidence and mortality between 2019 and 2050
5. Net Clinical Benefit of Oral Anticoagulation Among Frail Patients With Atrial Fibrillation: Nationwide Cohort Study
6. Epidemiological Trends and Projections of Incidence, Prevalence, and Disease Related Mortality Associated With Peripheral Arterial Disease: Observations Using Nationwide Danish Data
7. Risk of recurrent cancer-associated venous thromboembolism: A Danish nationwide cohort study
8. Validity of obstructive sleep apnoea diagnoses
9. Validation of the Khorana score for predicting venous thromboembolism in 40 218 patients with cancer initiating chemotherapy
10. First Trimester Anticoagulant Exposure and Adverse Pregnancy Outcomes in Women with Preconception Venous Thromboembolism: A Nationwide Cohort Study
11. Thromboembolic Risk in Nonanticoagulated Patients With Atrial Fibrillation and Valvular Heart Disease
12. Albuminuria and Risk of Cardiovascular Events and Mortality in a General Population of Patients with Type 2 Diabetes Without Cardiovascular Disease: A Danish Cohort Study
13. Predictors of Not Initiating Anticoagulation After Incident Venous Thromboembolism: A Danish Nationwide Cohort Study
14. Evaluation of the C2HEST Risk Score as a Possible Opportunistic Screening Tool for Incident Atrial Fibrillation in a Healthy Population (From a Nationwide Danish Cohort Study)
15. CHA2DS2-VASc or a non-sex score (CHA2DS2-VA) for stroke risk prediction in atrial fibrillation: contemporary insights and clinical implications.
16. Stroke risk in female patients with atrial fibrillation: Relationship to current guideline recommendations
17. Navigating the Passage for Better Understanding and Prognosis for Acute Limb Ischemia After Lower-Extremity Revascularization
18. Effectiveness and safety of direct oral anticoagulation versus warfarin in frail patients with atrial fibrillation
19. Sex differences in stroke risk have changed: should we reconsider risk stratification?
20. Risk of Recurrent Venous Thromboembolism: A Danish Nationwide Cohort Study
21. Rivaroxaban Versus Warfarin and Risk of Post-Thrombotic Syndrome Among Patients with Venous Thromboembolism
22. Restarting oral anticoagulant therapy after major bleeding in atrial fibrillation: A systematic review and meta-analysis
23. Sex differences in risk of incident venous thromboembolism in heart failure patients
24. Effectiveness and safety of direct oral anticoagulation vs. warfarin in frail patients with atrial fibrillation
25. Using a personalized decision support algorithm for dosing in warfarin treatment: A randomised controlled trial
26. Non–Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Atrial Fibrillation Patients With Intracerebral Hemorrhage
27. Glycemic Status and Thromboembolic Risk in Patients With Atrial Fibrillation and Type 2 Diabetes Mellitus: A Danish Cohort Study
28. Atrial Fibrillation Patients Categorized as “Not for Anticoagulation” According to the 2014 Canadian Cardiovascular Society Algorithm Are Not “Low Risk”
29. Risk of stroke or systemic embolism in patients with degenerative mitral stenosis with or without atrial fibrillation: A cohort study
30. Long-Term Management of Pulmonary Embolism: A Review of Consequences, Treatment, and Rehabilitation
31. Risk of Recurrent Venous Thromboembolism in Selected Subgroups of Men: A Danish Nationwide Cohort Study
32. The Value of the European Society of Cardiology Guidelines for Refining Stroke Risk Stratification in Patients With Atrial Fibrillation Categorized as Low Risk Using the Anticoagulation and Risk Factors in Atrial Fibrillation Stroke Score: A Nationwide Cohort Study
33. Improvement of anticoagulant treatment using a dynamic decision support algorithm: A Danish Cohort study
34. Response by Overvad et al to Letter Regarding Article, “Female Sex Is a Risk Modifier Rather Than a Risk Factor for Stroke in Atrial Fibrillation: Should We Use a CHA2DS2-VA Score Rather Than CHA2DS2-VASc?”
35. Female Sex Is a Risk Modifier Rather Than a Risk Factor for Stroke in Atrial Fibrillation: Should We Use a CHA2DS2-VA Score Rather Than CHA2DS2-VASc?
36. Effectiveness and safety of self-managed oral anticoagulant therapy compared with direct oral anticoagulants in patients with atrial fibrillation
37. Risk of Cerebrovascular Events in Intracerebral Hemorrhage Survivors With Atrial Fibrillation: A Nationwide Cohort Study
38. Monitoring of anticoagulant therapy applying a dynamic statistical model
39. The HAS-BLED, ATRIA, and ORBIT Bleeding Scores in Atrial Fibrillation Patients Using Non-Vitamin K Antagonist Oral Anticoagulants
40. All Types of Hemorrhagic Stroke Are Not Created Equally—Reply
41. Letter by Nielsen and Johnsen Regarding Article, “Optimal Timing of Anticoagulant Treatment After Intracerebral Hemorrhage in Patients With Atrial Fibrillation”
42. Effectiveness and safety of reduced dose non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study
43. Adding Rigor to Stroke Rate Investigations in Patients With Atrial Fibrillation
44. Positive Predictive Value of Non-Traumatic Bleeding Diagnoses in the Danish National Patient Register.
45. Renal function and non-vitamin K oral anticoagulants in comparison with warfarin on safety and efficacy outcomes in atrial fibrillation patients: a systemic review and meta-regression analysis
46. Disparities in oral anticoagulation initiation in patients with schizophrenia and atrial fibrillation: A nationwide cohort study
47. RISK OF RECURRENT VENOUS THROMBOEMBOLISM IN SUBGROUPS OF MEN: A NATIONWIDE COHORT STUDY
48. Hematuria in anticoagulated patients with atrial fibrillation and urologic cancer
49. Oral anti‐coagulant treatment patterns in atrial fibrillation patients diagnosed with cancer: A Danish nationwide cohort study
50. Effectiveness and Safety of NOAC Versus Warfarin in Patients With Atrial Fibrillation and Aortic Stenosis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.